Quantcast

US Proton Therapy Outlook 2017

March 13, 2014

DUBLIN, March 13, 2014 /PRNewswire/ –

Research and Markets (
http://www.researchandmarkets.com/research/8rl45x/us_proton_therapy) have announced
the addition of the “US Proton Therapy Outlook 2017″
[http://www.researchandmarkets.com/research/8rl45x/us_proton_therapy ] report to their
offering.

(Logo:
http://photos.prnewswire.com/prnh/20130307/600769 )

Physicians, in the face of an alarmingly rising incidences of cancer and limited
treatment options are being forced to look for treatments beyond the conventional ones. In
such a scenario, Proton Therapy, the most advanced radiation technique available, is being
projected as the Rolls Royce of Radiation Oncology. Unfortunately, access to proton
therapy is limited for many patients due to the low number of proton therapy centers.
Hence, many research institutes and hospitals are now investing in proton therapy to make
it more accessible to patients.

According to the US Proton Therapy Outlook 2017, the United States will be home to
almost 27 such centers by 2017, a number, which is almost double the current figure.
Consequentially, the market will breach the Billion dollar mark to attain revenue of US$
1.17 Billion by 2017. The following 65 pages report provides an insight into the cancer
demographics of US and the various possible causes for a high incidence there. The
document covers the historical trend (2008-2013) of cancer incidences, deaths and
prevalence along with state-wide and site-wide cancer incidences in the country.

It describes the various types of radiation therapies, which can be used to treat
cancer, as well as their disadvantages. Special attention has been given on proton therapy
and its benefits that make it stand out amidst the conventional treatment options. The
study dedicates a complete chapter on the various components of any proton therapy center
and covers issues related to accelerators, delivery, transportation, planning and
positioning systems to human resources required to setup a center.

As for the market, the report provides the state-wide distribution of proton therapy
centers in USA. A thorough analysis has been done on the existing and upcoming proton
therapy centers to measure the market size and its future condition. The report further
provides the state-wise statistics of potential patients for proton therapy and the
latter’s current market penetration. This is then followed by a section dedicated to
market opportunity assessment which would help service providers and vendors to extract
benefits from the largely untapped but lucrative market.

After a thorough analysis of the market, the authors have deduced various trends,
drivers and challenges which will have a major influence on shaping the growing market. On
the competitive front, the report covers the current stand and its probable transformation
by 2017 for service providers and equipment vendors. There is also a strengths-weakness’
analysis of equipment vendors along with their business overviews, products & services,
and existing & planned installations in US till 2017 in the report, thus making it a must
read for consultants and companies planning to enter the market.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. US Cancer Demographics

4. Current Radiation Therapies

5. Components of a Standard Proton Therapy Center

6. US Proton Therapy Market Outlook to 2017

7. Reimbursement Scenario

8. Industry Drivers and Restraints

9. Competitive Landscape and Strategic Analysis

Companies Mentioned:

        - Hitachi
        - IBA
        - Mevion Medical Systems
        - Varian

For more information visit

http://www.researchandmarkets.com/research/8rl45x/us_proton_therapy

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


    Photo: 

http://photos.prnewswire.com/prnh/20130307/600769

SOURCE Research and Markets


Source: PR Newswire



comments powered by Disqus